Admelog and Glipizide Extended-Release Tablets
Determining the interaction of Admelog and Glipizide Extended-Release Tablets and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.ADJUST DOSE: Coadministration of a sulfonylurea with insulin may potentiate the risk of hypoglycemia. Elderly, debilitated, or malnourished patients, and those with adrenal or pituitary insufficiency, are particularly susceptible to the hypoglycemic action of glucose-lowering drugs. MANAGEMENT: Caution and close blood glucose monitoring are advised during coadministration of these agents. A lower dosage of sulfonylurea or insulin may be required. Patients should be counseled to recognize the symptoms of hypoglycemia such as headache, dizziness, drowsiness, nervousness, confusion, tremor, hunger, weakness, perspiration, palpitation, and tachycardia. If hypoglycemia occurs, patients should initiate appropriate remedial therapy immediately and contact their physician. Patients should also be advised to take precautions to avoid hypoglycemia while driving or operating hazardous machinery. References "Product Information. Glucotrol (glipizide)." Pfizer US Pharmaceuticals, New York, NY. "Product Information. Humulin R (insulin regular)." Lilly, Eli and Company, Indianapolis, IN. Cerner Multum, Inc. "Australian Product Information." O 0 "Product Information. Humulin N (insulin isophane)." Lilly, Eli and Company, Indianapolis, IN. "Product Information. Afrezza (insulin inhalation, rapid acting)." MannKind Corporation, Valencia, CA. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0 "Product Information. Diabeta (glyburide)." Hoechst Marion-Roussel Inc, Kansas City, MO. "Product Information. Amaryl (glimepiride)." Hoechst Marion-Roussel Inc, Kansas City, MO. "Product Information. NovoLIN R (insulin regular)." Novo Nordisk Pharmaceuticals Inc, Princeton, NJ. American Diabetes Association "9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2019" Diabetes Care 42 (2019): S90-S102 View all 10 references
Professional:ADJUST DOSE: Coadministration of a sulfonylurea with insulin may potentiate the risk of hypoglycemia. Elderly, debilitated, or malnourished patients, and those with adrenal or pituitary insufficiency, are particularly susceptible to the hypoglycemic action of glucose-lowering drugs.
MANAGEMENT: Caution and close blood glucose monitoring are advised during coadministration of these agents. A lower dosage of sulfonylurea or insulin may be required. Patients should be counseled to recognize the symptoms of hypoglycemia such as headache, dizziness, drowsiness, nervousness, confusion, tremor, hunger, weakness, perspiration, palpitation, and tachycardia. If hypoglycemia occurs, patients should initiate appropriate remedial therapy immediately and contact their physician. Patients should also be advised to take precautions to avoid hypoglycemia while driving or operating hazardous machinery.
- "Product Information. Glucotrol (glipizide)." Pfizer US Pharmaceuticals, New York, NY.
- "Product Information. Humulin R (insulin regular)." Lilly, Eli and Company, Indianapolis, IN.
- Cerner Multum, Inc. "Australian Product Information." O 0
- "Product Information. Humulin N (insulin isophane)." Lilly, Eli and Company, Indianapolis, IN.
- "Product Information. Afrezza (insulin inhalation, rapid acting)." MannKind Corporation, Valencia, CA.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- "Product Information. Diabeta (glyburide)." Hoechst Marion-Roussel Inc, Kansas City, MO.
- "Product Information. Amaryl (glimepiride)." Hoechst Marion-Roussel Inc, Kansas City, MO.
- "Product Information. NovoLIN R (insulin regular)." Novo Nordisk Pharmaceuticals Inc, Princeton, NJ.
- American Diabetes Association "9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2019" Diabetes Care 42 (2019): S90-S102
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: n.a.
Generic Name: glipizide
Brand name: Glucotrol, Glucotrol XL, Glipizide XL
Synonyms: Glipizide, GlipiZIDE
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Admelog-Glipizide Tablets
- Admelog-Glipizide XL
- Admelog-Glofil-125
- Admelog-Gloperba
- Admelog-GloStrips
- Admelog-Glucagen
- Glipizide Extended-Release Tablets-Admelog (Insulin Lispro (U-100) Cartridges and Pens)
- Glipizide Extended-Release Tablets-Admelog (Insulin Lispro (U-100) Vials)
- Glipizide Extended-Release Tablets-Ado-trastuzumab emtansine
- Glipizide Extended-Release Tablets-Ado-trastuzumab emtansine Intravenous
- Glipizide Extended-Release Tablets-Adox Pak 2/100
- Glipizide Extended-Release Tablets-Adoxa